FDA Inspection 1203661 — Abbott Ireland Limited

Abbott Ireland Limited — FEI 3008344661

The FDA completed an inspection of Abbott Ireland Limited on January 27, 2023 in Sligo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 27, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Sligo (Ireland)